Acute Cystitis vs Acute Pyelonephritis

Why Acute uncomplicated cystitis is correct

• Dysuria, frequency, and urgency with pyuria and positive nitrites in a healthy nonpregnant woman define acute uncomplicated cystitis.
• Nitrites indicate nitrate-reducing Enterobacterales such as E coli, the dominant uropathogen.
• The absence of fever, flank pain, or systemic illness keeps this confined to the bladder.

Why the others are wrong

• Chlamydia trachomatis urethritis — STI-mimic trap: chlamydia can cause dysuria and pyuria in young women, but it does not reduce nitrate to nitrite and typically produces sterile pyuria, often with mucopurulent cervical discharge; the positive nitrite points to Enterobacterales in the bladder instead.
• Painful bladder syndrome — Chronic-mimic trap: also called interstitial cystitis, this diagnosis of exclusion requires bladder pain with urgency and frequency for more than 6 weeks after infection is ruled out, so nitrite-positive pyuria points to infection instead.
• Overactive bladder syndrome — Symptom-overlap trap: overactive bladder causes urgency and frequency but not dysuria, and it is diagnosed only after infection is excluded, which the leukocyte esterase and nitrites here do not allow.

Why Oral fluoroquinolone antibiotic course is correct

• A stable, nonpregnant adult with acute pyelonephritis who can take oral therapy can be treated as an outpatient with an oral fluoroquinolone where fluoroquinolone resistance is low.
• Fever, CVA tenderness, and pyuria with nitrites localize the infection to the upper tract.
• A urine culture should be sent first, but empiric therapy starts immediately; pregnancy or severe illness would mandate admission instead.

Why the others are wrong

• Oral nitrofurantoin five-day course — Cystitis-only trap: nitrofurantoin concentrates in bladder urine but does not reach therapeutic renal tissue or serum levels, so it should not be used for pyelonephritis.
• Single-dose oral fosfomycin therapy — Cystitis-regimen trap: single-dose fosfomycin is for uncomplicated cystitis only; oral fosfomycin does not achieve adequate renal tissue levels and is not recommended for pyelonephritis.
• Oral amoxicillin seven-day course — Oral beta-lactam trap: oral beta-lactams have weaker supporting data than fluoroquinolones for pyelonephritis and are reserved as alternatives, and amoxicillin alone is a poor empiric choice because aminopenicillin resistance among E. coli is common.

Additional high-yield points

• Oral TMP-SMX is an alternative when the uropathogen is known to be susceptible; 5-7 days of a fluoroquinolone is usually sufficient when the patient improves promptly (IDSA 2025).